保护胰岛功能及促进胰岛再生的临床治疗进展

被引：6

作者：

唐伟

段宇

刘超

机构：

[1] 南京医科大学附属第一医院内分泌科

来源：

国际内科学杂志 | 2009年 / 36卷 / 11期

关键词：

2型糖尿病; β细胞功能; 胰岛再生; 肠促胰岛素; 二肽酶-Ⅳ抑制剂;

D O I：

暂无

中图分类号：

R587.1 [糖尿病];

学科分类号：

100201 [内科学];

摘要：

胰岛功能受损是1型糖尿病的始动因素,也是2型糖尿病发病的中心环节。随着病程的进展,多种机制参与导致β细胞的功能进行性下降。如能够在早期及时发现β细胞的功能减退,并通过给予胰岛素强化治疗、钾通道开放剂、噻唑烷二酮类、血管紧张素转化酶抑制剂/血管紧张素受体Ⅰ拮抗剂、肠促胰岛素及类似物、二肽酶-Ⅳ抑制剂等药物及时有效地治疗以保护胰岛β细胞功能、促进胰岛再生,对糖尿病的防治具有重要意义。

引用

页码：643 / 647+651 +651

页数：6

共 11 条

[1]

Cytokine and Cytokine-Like Inflammation Markers, Endothelial Dysfunction, and Imbalanced Coagulation in Development of Diabetes and Its Complications [J].

Goldberg, Ronald B. .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2009, 94 (09) :3171-3182

[2]

Impact of new-onset diabetes mellitus on cardiac outcomes in the Valsartan Antihypertensive Long-Term Use Evaluation (VALUE) trial population [J].

Aksnes, Tonje A. ;

Kjeldsen, Sverre E. ;

Rostrup, Morten ;

Omvik, Per ;

Hua, Tsushung A. ;

Julius, Stevo .

HYPERTENSION, 2007, 50 (03) :467-473

[3]

Beneficial effects of candesartan; an angiotensin II type 1 receptor blocker; on β-cell function and morphology in db/db mice.[J].Jiaqing Shao;Noseki Iwashita;Fuki Ikeda;Takeshi Ogihara;Toyoyoshi Uchida;Tomoaki Shimizu;Hiroshi Uchino;Takahisa Hirose;Ryuzo Kawamori;Hirotaka Watada.Biochemical and Biophysical Research Communications.2006, 4

[4]

Glucagon-like peptide-1: physiology and therapeutic potential.[J].Jens Juul Holst.Current Opinion in Endocrinology & Diabetes.2005, 1

[5]

Dipeptidyl peptidase inhibitors as new drugs for the treatment of type 2 diabetes [J].

Mest, HJ ;

Mentlein, R .

DIABETOLOGIA, 2005, 48 (04) :616-620

[6]

Incretin mimetics as emerging treatments for type 2 diabetes [J].

Joy, SV ;

Rodgers, PT ;

Scates, AC .

ANNALS OF PHARMACOTHERAPY, 2005, 39 (01) :110-118

[7]

Effect of candesartan on cause-specific mortality in heart failure patients - The Candesartan in Heart failure Assessment of Reduction in Mortality and morbidity (CHARM) program [J].

Solomon, SD ;

Wang, DL ;

Finn, P ;

Skali, H ;

Zornoff, L ;

McMurray, JJV ;

Swedberg, K ;

Yusuf, S ;

Granger, CB ;

Michelson, EL ;

Pocock, S ;

Pfeffer, MA .

CIRCULATION, 2004, 110 (15) :2180-2183

[8]

Attenuation of hyperinsulinemia by NN414, a SUR1/Kir6.2 selective K+-adenosine triphosphate channel opener, improves glucose tolerance and lipid profile in obese Zucker rats [J].

Alemzadeh, R ;

Fledelius, C ;

Bodvarsdottir, T ;

Sturis, J .

METABOLISM-CLINICAL AND EXPERIMENTAL, 2004, 53 (04) :441-447

[9]

Decreased beta-cell mass in diabetes: significance, mechanisms and therapeutic implications [J].

Donath, MY ;

Halban, PA .

DIABETOLOGIA, 2004, 47 (03) :581-589

[10]

Development of diabetes is retarded by ACE inhibition in hypertensive patients – a subanalysis of the Captopril Prevention Project (CAPPP).[J].Anders Niklason;Thomas Hedner;Leo Niskanen;Jan Lanke.Journal of Hypertension.2004, 3

← 1 2 →